Hippocampal subfield vulnerability to α-synuclein pathology precedes neurodegeneration and cognitive dysfunction
Authors:
Open Access
- 29 August 2023
- journal article
- research article
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 9 (1) , 1-11
Abstract
Cognitive dysfunction is a salient feature of Parkinson’s disease (PD) and Dementia with Lewy bodies (DLB). The onset of dementia reflects the spread of Lewy pathology throughout forebrain structures. The mere presence of Lewy pathology, however, provides limited indication of cognitive status. Thus, it remains unclear whether Lewy pathology is the de facto substrate driving cognitive dysfunction in PD and DLB. Through application of α-synuclein fibrils in vivo, we sought to examine the influence of pathologic inclusions on cognition. Following stereotactic injection of α-synuclein fibrils within the mouse forebrain, we measured the burden of α-synuclein pathology at 1-, 3-, and 6-months post-injection within subregions of the hippocampus and cortex. Under this paradigm, the hippocampal CA2/3 subfield was especially susceptible to α-synuclein pathology. Strikingly, we observed a drastic reduction of pathology in the CA2/3 subfield across time-points, consistent with the consolidation of α-synuclein pathology into dense somatic inclusions followed by neurodegeneration. Silver-positive degenerating neurites were observed prior to neuronal loss, suggesting that this might be an early feature of fibril-induced neurotoxicity and a precursor to neurodegeneration. Critically, mice injected with α-synuclein fibrils developed progressive deficits in spatial learning and memory. These findings support that the formation of α-synuclein inclusions in the mouse forebrain precipitate neurodegenerative changes that recapitulate features of Lewy-related cognitive dysfunction.Keywords
All Related Versions
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (R56AG074473)
This publication has 67 references indexed in Scilit:
- Behavioral Characterization of A53T Mice Reveals Early and Late Stage Deficits Related to Parkinson’s DiseasePLOS ONE, 2013
- Characterization of Cognitive Deficits in Rats Overexpressing Human Alpha-Synuclein in the Ventral Tegmental Area and Medial Septum Using Recombinant Adeno-Associated Viral VectorsPLOS ONE, 2013
- Allen Brain Atlas: an integrated spatio-temporal portal for exploring the central nervous systemNucleic Acids Research, 2012
- Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic MiceScience, 2012
- Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in miceJournal of Experimental Medicine, 2012
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron DeathNeuron, 2011
- The Role of Axonopathy in Parkinson's DiseaseExperimental Neurobiology, 2010
- The propagation of prion-like protein inclusions in neurodegenerative diseasesTrends in Neurosciences, 2010
- The use of the elevated plus maze as an assay of anxiety-related behavior in rodentsNature Protocols, 2007
- The parkinson's complex: Parkinsonism is just the tip of the icebergAnnals of Neurology, 2006